Shengjie Hong
No. 3025 Shennan Middle Road
Shenzhen, 518033, China
Shenzhen, 518033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Retraction notice to "Molecular and cellular mechanisms of PDAC progression based on RETN-CAP1-mediated macrophage-fibroblast crosstalk: Action of ITGB5 and ITGB1 recombinant proteins" [Int. J. Biol. Macromol. 290 (2025) 139078].
Journal: International journal of biological macromolecules
Published: July 29, 2026
The prognostic significance of cholesterol, high-density lipoprotein and glucose (CHG) index in evaluating all-cause mortality risk in metabolic dysfunction-associated steatotic liver disease (MASLD) individuals: evidence from two cohort studies.
Journal: Cardiovascular diabetology
Published: February 01, 2026
LPCAT1 as a prognostic biomarker and risk indicator for hepatocellular carcinoma: insights into genes related to lipid metabolism.
Journal: Frontiers in oncology
Published: September 18, 2025
Nicotinamide N-Methyltransferase Inhibition Mitigates Cerulein-Induced Pancreatic Fibrosis via Galectin-3-Mediated Regulation of Stellate Cell Activation and Macrophage M2 Polarization in Mice.
Journal: Inflammation
Published: September 13, 2025
Identification of the CYP19A1-GPER1 axis as a critical oncogenic driver in hepatocellular carcinoma via AKT activation.
Journal: Journal of translational medicine
Published: September 01, 2025
UHRF1 ameliorates liver cirrhosis through suppressing macrophage M1 polarization by catalyzing HMGA2 promoter methylation.
Journal: Biochemical pharmacology
Published: July 22, 2025
Extrachromosomal DNA drives molecular and clinical heterogeneity in hepatocellular carcinoma: a multi-omics analysis and prognostic model development.
Journal: Human genomics
Published: April 08, 2025
2-Dodecyl-6-methoxycyclohexa-2,5-dien-1,4-dione alleviates liver fibrosis and improves intestinal flora and bile acid metabolism.
Journal: Frontiers in pharmacology
Published: February 21, 2025
Molecular and cellular mechanisms of PDAC progression based on RETN-CAP1-mediated macrophage-fibroblast crosstalk: Action of ITGB5 and ITGB1 recombinant proteins.
Journal: International journal of biological macromolecules
Published: November 12, 2024
Ansofaxine Hydrochloride inhibits hepatocellular carcinoma growth and enhances targeted therapy through the EGFR/MAPK pathway.
Journal: Frontiers in oncology
Published: November 06, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026